TH163399B - Synthesis 3- (5-amino-2-methyl-4-oxoquinazolin-3 (4H) -Il) piperidine-2,6-dione - Google Patents

Synthesis 3- (5-amino-2-methyl-4-oxoquinazolin-3 (4H) -Il) piperidine-2,6-dione

Info

Publication number
TH163399B
TH163399B TH1501006617A TH1501006617A TH163399B TH 163399 B TH163399 B TH 163399B TH 1501006617 A TH1501006617 A TH 1501006617A TH 1501006617 A TH1501006617 A TH 1501006617A TH 163399 B TH163399 B TH 163399B
Authority
TH
Thailand
Prior art keywords
amino
methyl
oxoquinazolin
piperidine
dione
Prior art date
Application number
TH1501006617A
Other languages
Thai (th)
Other versions
TH1501006617A (en
TH163399A (en
Original Assignee
เซลจีน คอร์ปอเรชั่น
Filing date
Publication date
Application filed by เซลจีน คอร์ปอเรชั่น filed Critical เซลจีน คอร์ปอเรชั่น
Publication of TH1501006617A publication Critical patent/TH1501006617A/en
Publication of TH163399A publication Critical patent/TH163399A/en
Publication of TH163399B publication Critical patent/TH163399B/en

Links

Abstract

แก้ไข 12/1/2559 โดยที่ถูกจัดใหไว้ในที่นี้คือ กระบวนการสำหรับการเตรียมของ 3-(5-อะมิโน-2-เมธิล-4- ออกโซควินาโซลิน-3(4H)-อิล)ไพเพอริดีน-2,6-ไดโอน, หรืออีแนนติโอเมอร์หรือของผสมจาก อีแนนติโอเมอร์ของมัน; หรือเกลือที่สามารถยอมรับได้ในทางเภสัชกรรมของมัน ---------------------------------------------------------------- ที่จัดให้มีในทีนี้เป็นกระบวนการสำหรับการเตรียม 3-(5-อะมิโน-2-เมทิล-4-ออกโซควินา โซลิน-3(4H)-อิล) ไพเพอริดิน-2,6- ไดโอน หรืออิเนนทิโอเมอร์หรือของผสมของอิแนนทิโอเมอร์ของ มัน หรือเกลือของมันที่ยอมรับได้ทางเภสัชกรรม Edit 12/1/2016, provided here is Process for the preparation of 3- (5-amino-2-methyl-4-oxoquinazolin-3 (4H) -Il) piperidine-2,6-dion, or enae Ntiomer or a mixture of Its nantiomer; Or its pharmaceutical salt -------------------------------------------------- -------------- Here provided is the process for preparing. 3- (5-amino-2-methyl-4-oxocquina Solin-3 (4H) - il) piperidin-2,6-dion or inanthiomer or a mixture of its inanthiomers or their salts. Acceptable pharmaceutical

TH1501006617A 2014-04-30 Synthesis 3- (5-amino-2-methyl-4-oxoquinazolin-3 (4H) -Il) piperidine-2,6-dione TH163399B (en)

Publications (3)

Publication Number Publication Date
TH1501006617A TH1501006617A (en) 2017-06-15
TH163399A TH163399A (en) 2017-06-15
TH163399B true TH163399B (en) 2017-06-15

Family

ID=

Similar Documents

Publication Publication Date Title
EA201791256A1 (en) HINAZOLIN DERIVATIVES USED FOR HIV TREATMENT
WO2016079751A3 (en) A process for preparation of vortioxetine and polymorphs thereof
DK3497081T3 (en) Process for the preparation of 4-ammonium-2,2,6,6-tetraalkylpiperidinyl salts
WO2016011390A8 (en) Irak4 inhibiting agents
UA122773C2 (en) Method for the preparation of (4s)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1-6-naphthyridine-3-carbox-amide and the purification thereof for use as an active pharmaceutical ingredient
WO2015132799A3 (en) Heterocyclic compounds
EA201791304A1 (en) IZOHINOLINA DERIVATIVES FOR HIV TREATMENT
WO2015110897A3 (en) Novel process for the preparation of dolutegravir and pharmaceutically acceptable salts thereof
EA032972B1 (en) Heterocyclic carboxylic acids as activators of soluble guanylate cyclase
MD3882250T2 (en) Tetrahydropyranyl amino-pyrrolopyrimidinone for use in treating btk-mediated disorders
PH12017500833A1 (en) Synthesis of copanlisib and its dihydrochloride salt
WO2015142903A3 (en) Method of controlling lactate production with piperdine-dione derivatives
CY1119525T1 (en) COMPOSITION OF 3- (5-AMINO-2-METHYL-4-OXOKINAZOLIN-3 (4H) -YL) PIPE-RIDINO-2,6-DIONIS
DK3054927T3 (en) FORMULATIONS OF (S) -3- (4 - ((4-MORPHOLINOMETHYL) BENZYLXYL) -1-OXOISOINDOLIN-2-YL) PIPERIDINE-2,6-DIONE
MY183123A (en) Synthesis of copanlisib and its di hydrochloride salt
AR105774A1 (en) PROCEDURE FOR THE PREPARATION OF (4S) -4- (4-CIANO-2-METOXYPHENYL) -5-ETOXI-2,8-DIMETHYL-1,4-DIHYDRO-1,6-NAFTIRIDINE-3-CARBOXAMIDE AND ITS PURIFICATION FOR ITS USE AS A PHARMACEUTICAL ACTIVE PRINCIPLE
IL249336A0 (en) Methods for the preparation of 1,3-benzodioxole heterocyclic compounds
EA201790235A1 (en) METHOD OF OBTAINING cGMP-PHOSPHODESTERASE INHIBITOR AND PHARMACEUTICAL PREPARATION FOR ORAL ADMINISTRATION CONTAINING TADALAFIL CO-PRICIPITATES
PH12018502246A1 (en) Substituted fused pyrimidinone compounds
BR112016021910A2 (en) PROCESS FOR THE PREPARATION OF 3-(3-(4-(1-AMINOCYCLOBUTYL)PHENYL)-5-PHENYL-3H-IMIDAZO[4,5-B]PYRIDIN-2-IL)PYRIDIN-2-AMINE
MX2018015269A (en) Derivatives of thailanstatin a, methods of treatment and methods of synthesis thereof.
TH163399B (en) Synthesis 3- (5-amino-2-methyl-4-oxoquinazolin-3 (4H) -Il) piperidine-2,6-dione
TH163399A (en) Synthesis 3- (5-amino-2-methyl-4-oxoquinazolin-3 (4H) -Il) piperidine-2,6-dione
MX2020009412A (en) Salts and polymorphs of a substituted imidazopyridinyl-aminopyrid ine compound.
MX2017004770A (en) Solid forms of nilotinib hydrochloride.